Cooley

Charlie Kim

Deals
6
Latest
Sep 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 6 deals
Deals by year
Charlie Kim: deals by year03620252026 YTD: 1 M&A2026 YTD: 5 Equity raisings62026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Charlie Kim was named on, most recent first
Sep 2026 Marea Therapeutics ––PlacementLegal adviser to the lead managersAnnounced225.0BiotechMarea Therapeutics placement
Jul 2026 Avere Therapeutics ––PlacementLegal adviser to the lead managersAnnounced320.0Biotech+1Avere Therapeutics placement
May 2026 Mentari Therapeutics ––PlacementLegal adviser to the lead managersAnnounced290.0Biotech+1Mentari Therapeutics placement
May 2026 Candid Therapeutics –UCBAcquisitionLegal adviser to Candid Therapeutics (target)Announced2,200.0Biotech+1UCB acquisition of Candid Therapeutics
Apr 2026 Korsana Biosciences ––PlacementLegal adviser to the lead managersAnnounced380.0Biotech+1Korsana Biosciences placement
Mar 2026 Candid Therapeutics ––PlacementLegal adviser to the issuerPending505.0Biotech+1Candid Therapeutics placement

Deals where Charlie Kim is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.